Skip to main content

Table 4 Prevalence (%) (95% confidence interval) in the nondiabetic population* of 1 to 5 of the NCEP ATP III risk factor components of the metabolic syndrome and diagnosis of metabolic syndrome

From: Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study

 

Number of Components

 

0

1

2

3

4

5

Overall

23.4 (22.3-24.5)

32.8 (31.7-34.0)

26.5 (25.4-27.6)

13.0 (12.2-13.8)

4.0 (3.6-4.4)

0.3 (0.2-0.4)

   Men

24.6 (23.1-26.2)

30.8 (29.1-32.4)

28.5 (26.9-30.0)

12.2 (11.1-13.4)

3.6 (3.0-4.1)

0.3 (0.1-0.5)

   Women

22.3 (20.8-23.8)

34.7 (33.0-36.3)

24.8 (23.3-26.2)

13.7 (12.5-14.8)

4.3 (3.8-4.9)

0.3 (0.1-0.4)

Barquisimeto

      

   Men

14.1 (11.2-16.7)

32.6 (28.3-37.0)

30.3 (26.5-34.1)

15.8 (12.8-18.8)

6.7 (4.7-8.8)

0.5 (0.0-1.0)

   Women

13.4 (10.9-16.0)

37.5 (33.8-41.2)

26.4 (23.4-29.5)

16.3 (14.0-18.5)

6.2 (4.7-7.8)

0.2 (0.0-0.3)

Bogota

      

   Men

21.6 (18.1-25.0)

30.7 (26.6-34.9)

33.0 (29.4-36.6)

11.4 (8.6-14.2)

3.0 (1.8-4.1)

0.3 (0.0-0.7)

   Women

17.6 (14.3-20.9)

35.4 (31.9-38.9)

28.8 (25.5-32.1)

14.0 (11.2-16.8)

4.0 (2.9-5.2)

0.2 (0.0-0.4)

Buenos Aires

      

   Men

28.5 (25.1-31.9)

30.2 (27.3-33.1)

24.0 (20.4-27.5)

12.7 (10.5-15.0)

4.4 (2.9-5.9)

0.2 (0.0-0.5)

   Women

37.7 (33.8-41.5)

36.7 (32.8-40.6)

15.9 (13.0-18.8)

7.5 (5.4-9.6)

2.1 (0.8-3.3)

0.1 (0.0-0.4)

Lima

      

   Men

21.5 (18.0-25.0)

35.8 (32.0-39.7)

29.5 (26.0-33.0)

9.7 (7.5-11.8)

3.2 (1.9-4.5)

0.3 (0.0-0.6)

   Women

12.1 (9.5-14.7)

44.2 (40.4-48.1)

26.1 (22.7-29.5)

13.2 (10.9-15.3)

4.2 (3.0-5.5)

0.2 (0.0-0.5)

Mexico City

      

   Men

23.7 (20.5-27.0)

26.0 (23.4-28.5)

27.9 (24.7-31.1)

17.3 (14.1-20.5)

4.6 (3.2-6.0)

0.5 (0.0-1.0)

   Women

24.3 (20.7-27.8)

27.5 (24.1-31.0)

26.0 (22.9-29.0)

16.7 (14.0-19.4)

5.0 (3.7-6.3)

0.5 (0.0-1.0)

Quito

      

   Men

39.2 (34.8-43.5)

32.5 (28.9-36.0)

22.8 (19.8-25.9)

4.3 (2.9-5.8)

1.1 (0.4-1.8)

0.1 (0.0-0.2)

   Women

30.5 (26.9-34.1)

30.9 (27.2-34.5)

22.2 (18.8-25.7)

13.4 (10.8-16.1)

2.7 (1.7-3.6)

0.3 (0.0-0.6)

Santiago

      

   Men

28.6 (24.5-32.6)

29.8 (25.6-33.9)

26.3 (22.7-29.9)

11.7 (9.5-14.1)

3.3 (2.0-4.5)

0.3 (0.0-0.7)

   Women

28.6 (24.8-32.3)

30.5 (26.9-34.2)

21.9 (19.1-24.8)

13.3 (10.8-15.8)

5.5 (3.8-7.1)

0.2 (0.0-0.5)

  1. *CARMELA participants excluding participants with fasting plasma glucose ≥ 7.0 mmol/l (126 mg/dL) and/or self-reported diabetes.